6:35 am Transition Therapeutics announces development update; co will seek to leverage the economic benefits of ELND005 and future in-licensed assets through its recently acquired Irish domiciled subsidiary, Transition Therapeutics Ireland
View todays social media effects on TTHI
View the latest stocks trending across Twitter. Click to view dashboard